Logo image of CHR.CA

CHORUS AVIATION INC (CHR.CA) Stock Fundamental Analysis

Canada - TSX:CHR - CA17040T8885 - Common Stock

23.09 CAD
-0.03 (-0.13%)
Last: 10/29/2025, 7:00:00 PM
Fundamental Rating

4

CHR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 7 industry peers in the Passenger Airlines industry. CHR has an average financial health and profitability rating. CHR is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CHR was profitable.
CHR had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CHR reported negative net income in multiple years.
CHR had a positive operating cash flow in each of the past 5 years.
CHR.CA Yearly Net Income VS EBIT VS OCF VS FCFCHR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

CHR has a Return On Assets (-1.91%) which is in line with its industry peers.
With a Return On Equity value of -4.82%, CHR perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
CHR's Return On Invested Capital of 6.54% is amongst the best of the industry. CHR outperforms 100.00% of its industry peers.
CHR had an Average Return On Invested Capital over the past 3 years of 5.30%. This is in line with the industry average of 5.73%.
The last Return On Invested Capital (6.54%) for CHR is above the 3 year average (5.30%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -1.91%
ROE -4.82%
ROIC 6.54%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
CHR.CA Yearly ROA, ROE, ROICCHR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

1.3 Margins

Looking at the Operating Margin, with a value of 6.87%, CHR is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
In the last couple of years the Operating Margin of CHR has declined.
CHR's Gross Margin of 65.48% is amongst the best of the industry. CHR outperforms 100.00% of its industry peers.
CHR's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.87%
PM (TTM) N/A
GM 65.48%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
CHR.CA Yearly Profit, Operating, Gross MarginsCHR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

4

2. Health

2.1 Basic Checks

CHR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CHR has been reduced compared to 1 year ago.
CHR has more shares outstanding than it did 5 years ago.
CHR has a better debt/assets ratio than last year.
CHR.CA Yearly Shares OutstandingCHR.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CHR.CA Yearly Total Debt VS Total AssetsCHR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 0.92, we must say that CHR is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.92, CHR perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
CHR has a debt to FCF ratio of 7.89. This is a slightly negative value and a sign of low solvency as CHR would need 7.89 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 7.89, CHR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
A Debt/Equity ratio of 0.54 indicates that CHR is somewhat dependend on debt financing.
CHR has a Debt to Equity ratio of 0.54. This is amongst the best in the industry. CHR outperforms 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 7.89
Altman-Z 0.92
ROIC/WACC0.77
WACC8.45%
CHR.CA Yearly LT Debt VS Equity VS FCFCHR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.14 indicates that CHR should not have too much problems paying its short term obligations.
CHR has a Current ratio (1.14) which is in line with its industry peers.
CHR has a Quick Ratio of 1.14. This is a bad value and indicates that CHR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.61, CHR is in line with its industry, outperforming 42.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.61
CHR.CA Yearly Current Assets VS Current LiabilitesCHR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 78.57% over the past year.
CHR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -19.03% yearly.
Looking at the last year, CHR shows a very negative growth in Revenue. The Revenue has decreased by -13.36% in the last year.
The Revenue has been growing slightly by 0.56% on average over the past years.
EPS 1Y (TTM)78.57%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%842.86%
Revenue 1Y (TTM)-13.36%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-7.58%

3.2 Future

Based on estimates for the next years, CHR will show a small growth in Earnings Per Share. The EPS will grow by 1.21% on average per year.
Based on estimates for the next years, CHR will show a decrease in Revenue. The Revenue will decrease by -5.14% on average per year.
EPS Next Y55.31%
EPS Next 2Y12.98%
EPS Next 3Y1.21%
EPS Next 5YN/A
Revenue Next Year-4.85%
Revenue Next 2Y-3.49%
Revenue Next 3Y-5.14%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CHR.CA Yearly Revenue VS EstimatesCHR.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CHR.CA Yearly EPS VS EstimatesCHR.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

CHR is valuated reasonably with a Price/Earnings ratio of 10.26.
Compared to the rest of the industry, the Price/Earnings ratio of CHR indicates a rather cheap valuation: CHR is cheaper than 85.71% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.76. CHR is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 11.98, which indicates a very decent valuation of CHR.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CHR indicates a rather cheap valuation: CHR is cheaper than 85.71% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.63, CHR is valued a bit cheaper.
Industry RankSector Rank
PE 10.26
Fwd PE 11.98
CHR.CA Price Earnings VS Forward Price EarningsCHR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CHR's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CHR is cheaper than 71.43% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CHR is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.08
EV/EBITDA 4.31
CHR.CA Per share dataCHR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

CHR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.19
PEG (5Y)N/A
EPS Next 2Y12.98%
EPS Next 3Y1.21%

3

5. Dividend

5.1 Amount

CHR has a Yearly Dividend Yield of 1.38%.
Compared to an average industry Dividend Yield of 2.39, CHR has a dividend in line with its industry peers.
With a Dividend Yield of 1.38, CHR pays less dividend than the S&P500 average, which is at 2.31.
Industry RankSector Rank
Dividend Yield 1.38%

5.2 History

The dividend of CHR is nicely growing with an annual growth rate of 21.58%!
CHR has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)21.58%
Div Incr Years0
Div Non Decr Years0
CHR.CA Yearly Dividends per shareCHR.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2025 1 2 3

5.3 Sustainability

CHR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of CHR is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP-34.57%
EPS Next 2Y12.98%
EPS Next 3Y1.21%
CHR.CA Yearly Income VS Free CF VS DividendCHR.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

CHORUS AVIATION INC

TSX:CHR (10/29/2025, 7:00:00 PM)

23.09

-0.03 (-0.13%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-06 2025-11-06/amc
Inst Owners3.2%
Inst Owner ChangeN/A
Ins Owners1.35%
Ins Owner ChangeN/A
Market Cap588.33M
Revenue(TTM)1.37B
Net Income(TTM)-25868000
Analysts78
Price Target28.6 (23.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.38%
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-34.57%
Div Incr Years0
Div Non Decr Years0
Ex-Date07-31 2025-07-31 (0.08)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.45%
Min EPS beat(2)3.87%
Max EPS beat(2)11.03%
EPS beat(4)4
Avg EPS beat(4)62.09%
Min EPS beat(4)3.87%
Max EPS beat(4)207.96%
EPS beat(8)5
Avg EPS beat(8)11.1%
EPS beat(12)6
Avg EPS beat(12)4.98%
EPS beat(16)8
Avg EPS beat(16)3.11%
Revenue beat(2)0
Avg Revenue beat(2)-6.13%
Min Revenue beat(2)-8.31%
Max Revenue beat(2)-3.95%
Revenue beat(4)0
Avg Revenue beat(4)-6%
Min Revenue beat(4)-8.31%
Max Revenue beat(4)-3.78%
Revenue beat(8)3
Avg Revenue beat(8)-2.48%
Revenue beat(12)5
Avg Revenue beat(12)-1.45%
Revenue beat(16)8
Avg Revenue beat(16)1.16%
PT rev (1m)0%
PT rev (3m)1.31%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.64%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.63%
Valuation
Industry RankSector Rank
PE 10.26
Fwd PE 11.98
P/S 0.43
P/FCF 12.08
P/OCF 6.96
P/B 1.1
P/tB 1.11
EV/EBITDA 4.31
EPS(TTM)2.25
EY9.74%
EPS(NY)1.93
Fwd EY8.35%
FCF(TTM)1.91
FCFY8.28%
OCF(TTM)3.32
OCFY14.37%
SpS53.68
BVpS21.08
TBVpS20.74
PEG (NY)0.19
PEG (5Y)N/A
Graham Number32.67
Profitability
Industry RankSector Rank
ROA -1.91%
ROE -4.82%
ROCE 8.82%
ROIC 6.54%
ROICexc 6.9%
ROICexgc 6.96%
OM 6.87%
PM (TTM) N/A
GM 65.48%
FCFM 3.56%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexgc growth 3Y33.52%
ROICexgc growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score5
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 7.89
Debt/EBITDA 1.36
Cap/Depr 30.21%
Cap/Sales 2.62%
Interest Coverage 2.06
Cash Conversion 39.75%
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 0.61
Altman-Z 0.92
F-Score5
WACC8.45%
ROIC/WACC0.77
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.57%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%842.86%
EPS Next Y55.31%
EPS Next 2Y12.98%
EPS Next 3Y1.21%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.36%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-7.58%
Revenue Next Year-4.85%
Revenue Next 2Y-3.49%
Revenue Next 3Y-5.14%
Revenue Next 5YN/A
EBIT growth 1Y-53.02%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year86.18%
EBIT Next 3Y12.53%
EBIT Next 5YN/A
FCF growth 1Y-79.47%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-70.44%
OCF growth 3Y12.73%
OCF growth 5Y0.25%

CHORUS AVIATION INC / CHR.CA FAQ

What is the fundamental rating for CHR stock?

ChartMill assigns a fundamental rating of 4 / 10 to CHR.CA.


What is the valuation status for CHR stock?

ChartMill assigns a valuation rating of 7 / 10 to CHORUS AVIATION INC (CHR.CA). This can be considered as Undervalued.


Can you provide the profitability details for CHORUS AVIATION INC?

CHORUS AVIATION INC (CHR.CA) has a profitability rating of 5 / 10.


What are the PE and PB ratios of CHORUS AVIATION INC (CHR.CA) stock?

The Price/Earnings (PE) ratio for CHORUS AVIATION INC (CHR.CA) is 10.26 and the Price/Book (PB) ratio is 1.1.


What is the expected EPS growth for CHORUS AVIATION INC (CHR.CA) stock?

The Earnings per Share (EPS) of CHORUS AVIATION INC (CHR.CA) is expected to grow by 55.31% in the next year.